CG Oncology CGON Deferred Tax Assets and Other Non-Current Assets
Deferred Tax Assets and Other Non-Current Assets at other companies
Other financials
Where this comes from
Reported directly by CG Oncology in its filing.
Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.
The official record: CG Oncology’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about CG Oncology's deferred tax assets and other non-current assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is CG Oncology's deferred tax assets and other non-current assets?
- CG Oncology (CGON) reported deferred tax assets and other non-current assets of $2.68M in Q1 2026.
- How has CG Oncology's deferred tax assets and other non-current assets changed year-over-year?
- CG Oncology's deferred tax assets and other non-current assets increased by 418.6% year-over-year, from $516K to $2.68M.
- What is the long-term trend for CG Oncology's deferred tax assets and other non-current assets?
- Over 2 years (2023 to 2025), CG Oncology's deferred tax assets and other non-current assets has grown at a 839.8% compound annual growth rate (CAGR), from $19K to $1.68M.